Literature DB >> 33488597

HLA, Immune Response, and Susceptibility to COVID-19.

Fataneh Tavasolian1, Mohsen Rashidi2, Gholam Reza Hatam3, Marjan Jeddi4, Ahmad Zavaran Hosseini5, Sayed Hussain Mosawi6,7, Elham Abdollahi8, Robert D Inman1,9.   

Abstract

The severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) that appeared in December 2019 has precipitated the global pandemic Coronavirus Disease 2019 (COVID-19). However, in many parts of Africa fewer than expected cases of COVID-19, with lower rates of mortality, have been reported. Individual human leukocyte antigen (HLA) alleles can affect both the susceptibility and the severity of viral infections. In the case of COVID-19 such an analysis may contribute to identifying individuals at higher risk of the disease and the epidemiological level to understanding the differences between countries in the epidemic patterns. It is also recognized that first antigen exposure influences the consequence of subsequent exposure. We thus propose a theory incorporating HLA antigens, the "original antigenic sin (OAS)" effect, and presentation of viral peptides which could explain with differential susceptibility or resistance to SARS-CoV-2 infections.
Copyright © 2021 Tavasolian, Rashidi, Hatam, Jeddi, Hosseini, Mosawi, Abdollahi and Inman.

Entities:  

Keywords:  Coronavirus Disease 2019; human leukocyte antigens; immune response; original antigenic sin; vaccine design

Mesh:

Substances:

Year:  2021        PMID: 33488597      PMCID: PMC7820778          DOI: 10.3389/fimmu.2020.601886

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  62 in total

1.  The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.

Authors: 
Journal:  Eur J Hum Genet       Date:  2020-05-13       Impact factor: 4.246

Review 2.  Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review.

Authors:  Ihsane Benlyamani; Fabienne Venet; Rémy Coudereau; Morgane Gossez; Guillaume Monneret
Journal:  Cytometry A       Date:  2020-11-04       Impact factor: 4.355

Review 3.  HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis.

Authors:  Alessandro Mathieu; Alberto Cauli; Maria Teresa Fiorillo; Rosa Sorrentino
Journal:  Autoimmun Rev       Date:  2008-04-09       Impact factor: 9.754

Review 4.  Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.

Authors:  Marek Wieczorek; Esam T Abualrous; Jana Sticht; Miguel Álvaro-Benito; Sebastian Stolzenberg; Frank Noé; Christian Freund
Journal:  Front Immunol       Date:  2017-03-17       Impact factor: 7.561

5.  Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope.

Authors:  Payton A Weidenbacher; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-26       Impact factor: 11.205

6.  Pausing the Fight Against Malaria to Combat the COVID-19 Pandemic in Africa: Is the Future of Malaria Bleak?

Authors:  Nora Nganyewo Nghochuzie; Charles Ochieng' Olwal; Aniefiok John Udoakang; Lucas Naam-Kayagre Amenga-Etego; Alfred Amambua-Ngwa
Journal:  Front Microbiol       Date:  2020-06-18       Impact factor: 5.640

7.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

8.  Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome.

Authors:  Margaret H L Ng; Kin-Mang Lau; Libby Li; Suk-Hang Cheng; Wing Y Chan; Pak K Hui; Benny Zee; Chi-Bon Leung; Joseph J Y Sung
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

9.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

10.  Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.

Authors:  Ignacio Iturrieta-Zuazo; Claudia Geraldine Rita; Ana García-Soidán; Ana de Malet Pintos-Fonseca; Nieves Alonso-Alarcón; Roberto Pariente-Rodríguez; Amalia Tejeda-Velarde; Sergio Serrano-Villar; José Luis Castañer-Alabau; Israel Nieto-Gañán
Journal:  Clin Immunol       Date:  2020-08-15       Impact factor: 3.969

View more
  20 in total

1.  SARS-CoV-2 Host Immunogenetic Biomarkers.

Authors:  Maemu P Gededzha; Nakampe Mampeule; Anastasia Gandini; Elizabeth S Mayne
Journal:  Methods Mol Biol       Date:  2022

2.  Simulation of Scenarios of a Deep Population Crisis in a Rapidly Growing Population.

Authors:  A Yu Perevaryukha
Journal:  Biophysics (Oxf)       Date:  2022-02-10

Review 3.  Genetics Insight for COVID-19 Susceptibility and Severity: A Review.

Authors:  Ingrid Fricke-Galindo; Ramcés Falfán-Valencia
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

4.  Host polymorphisms and COVID-19 infection.

Authors:  Joris R Delanghe; Marijn M Speeckaert
Journal:  Adv Clin Chem       Date:  2021-08-23       Impact factor: 5.394

5.  Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2.

Authors:  Kanako Shimizu; Tomonori Iyoda; An Sanpei; Hiroshi Nakazato; Masahiro Okada; Shogo Ueda; Miyuki Kato-Murayama; Kazutaka Murayama; Mikako Shirouzu; Naoko Harada; Michihiro Hidaka; Shin-Ichiro Fujii
Journal:  Commun Biol       Date:  2021-12-02

6.  EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes.

Authors:  Cristina S Ferreira; Yasmmin C Martins; Rangel Celso Souza; Ana Tereza R Vasconcelos
Journal:  PeerJ       Date:  2021-11-30       Impact factor: 2.984

7.  An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World's Population.

Authors:  Andrés Felipe Cuspoca; Laura Lorena Díaz; Alvaro Fernando Acosta; Marcela Katherine Peñaloza; Yardany Rafael Méndez; Diana Carolina Clavijo; Juvenal Yosa Reyes
Journal:  Vaccines (Basel)       Date:  2021-06-01

Review 8.  Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.

Authors:  Filippo Migliorini; Ernesto Torsiello; Filippo Spiezia; Francesco Oliva; Markus Tingart; Nicola Maffulli
Journal:  Eur J Med Res       Date:  2021-08-03       Impact factor: 2.175

Review 9.  Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications.

Authors:  Yuda Turana; Michael Nathaniel; Robert Shen; Soegianto Ali; Rajender R Aparasu
Journal:  Brain Sci       Date:  2021-12-31

10.  HLA-B*15 predicts survival in Egyptian patients with COVID-19.

Authors:  Ahmed Samir Abdelhafiz; Asmaa Ali; Merhan A Fouda; Douaa M Sayed; Mahmoud M Kamel; Lamyaa Mohamed Kamal; Mahmoud Ali Khalil; Rania M Bakry
Journal:  Hum Immunol       Date:  2021-09-27       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.